ArticleAmerican journal of cancer research2022

PI3K inhibitors in trastuzumab-resistant HER2-positive breast cancer cells with PI3K pathway alterations.

Wei-Pang Chung et al.PubMed ↗Full text ↗

No numbers read from the abstract.